ProUroCare seeks FDA approval for prostate cancer monitoring device

11/29/2009 | Star Tribune (Minneapolis-St. Paul, Minn.)

ProUroCare Medical has submitted an application to the FDA seeking approval for a device that can generate 3-D images of the prostate gland to track prostate cancer. The startup firm said its technology quantifies tissue elasticity to enable physicians to conduct preliminary biopsies and monitor cancer progression.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC